Respiratory Syncytial Virus-related Death in Children With Down Syndrome The RSV GOLD Study

被引:20
|
作者
Lowensteyn, Yvette N. [1 ]
Phijffer, Emily W. E. M. [1 ]
Simons, Juliette V. L. [1 ]
Scheltema, Nienke M. [1 ]
Mazur, Natalie I. [1 ]
Nair, Harish [2 ,3 ]
Bont, Louis J. [1 ,3 ]
机构
[1] Univ Med Ctr Utrecht, Dept Pediat, Div Infect Dis, Utrecht, Netherlands
[2] Univ Edinburgh, Resp Viral Epidemiol Grp, Ctr Global Hlth Res, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland
[3] Resp Syncytial Virus Network ReSViNET Fdn, Zeist, Netherlands
基金
比尔及梅琳达.盖茨基金会; 英国惠康基金;
关键词
Down syndrome; respiratory syncytial virus; acute respiratory tract infection; mortality; YOUNG-CHILDREN; HIGH-RISK; RECURRENT WHEEZE; HOSPITALIZATION; INFECTIONS; INFANTS; DISEASE; BURDEN; PALIVIZUMAB;
D O I
10.1097/INF.0000000000002666
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Respiratory syncytial virus (RSV) is a major cause of mortality in children younger than 5 years worldwide. Systematic reviews have shown that Down syndrome (DS) is an independent risk factor for severe RSV infection. We aimed to describe demographic and clinical characteristics of children with DS who died with RSV infection. Methods: We performed a retrospective case series in which data were shared by individual researchers, research networks and physicians worldwide as part of the RSV Global Online Database study. We included children with DS who died when younger than 5 years of age with laboratory-confirmed RSV infection. Results: We included 53 children with DS and RSV-related mortality from 20 countries in 5 continents. Five (9.4%) children were from low-income or lower-middle-income countries. Median age at time of death was 6.0 months [interquartile range (IQR): 3.00-12.0]. Thirteen (24.5%) children were born term and had no other risk factors for severe RSV disease. In total, 36 (67.9%) children had congenital heart disease, 8 (15.1%) had chronic lung disease and 1 (1.9%) had congenital immunodeficiency. Duration of hospitalization was significantly longer for children with DS compared with children without DS [median length of stay, 13 days (IQR: 6.8-21.0) vs. 8 days (IQR: 3.0-18.5),P=0.005]. Conclusions: One-fourth of children with DS and RSV-confirmed death did not have risk factors for severe RSV disease, indicating that DS is an important risk factor for RSV-related mortality. Age distribution at time of death demonstrates that maternal vaccination would not be sufficient to protect children with DS against RSV-related mortality.
引用
收藏
页码:665 / 670
页数:6
相关论文
共 50 条
  • [21] Another case of respiratory syncytial virus-related limbic encephalitis
    Kengo Moriyama
    Yukitoshi Takahashi
    Takashi Shiihara
    Neuroradiology, 2014, 56 : 435 - 436
  • [22] Characteristics of respiratory syncytial virus-related apnoea in three infants
    Rayyan, M
    Naulaers, G
    Daniels, H
    Allegaert, K
    Debeer, A
    Devlieger, H
    ACTA PAEDIATRICA, 2004, 93 (06) : 847 - 849
  • [23] Virus-induced wheezing in children - Respiratory syncytial virus (RSV) and rhinovirus
    Heymann, PW
    Zambrano, JC
    Rakes, GP
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 1998, 18 (01) : 35 - +
  • [24] RESPIRATORY SYNCYTIAL VIRUS (RSV) OR ROUS-SARCOMA VIRUS (RSV)
    LINDHARDT, BO
    CHEST, 1995, 108 (01) : 292 - 292
  • [25] Rates of Respiratory Syncytial Virus Lower Respiratory Tract Infection Among Children With Down Syndrome
    Ammar, L.
    Riddell, C.
    Ding, T.
    Lee, R. L.
    Gebretsadik, T.
    Snyder, B. M.
    Hartert, T. V.
    Wu, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [26] The epidemiology of respiratory syncytial virus (RSV) infections in South African children
    Vardas, E
    Blaauw, D
    McAnerney, J
    SOUTH AFRICAN MEDICAL JOURNAL, 1999, 89 (10): : 1079 - 1084
  • [27] RECURRENT WHEEZING IN CHILDREN WITH RESPIRATORY SYNCYTIAL VIRUS (RSV) BRONCHIOLITIS IN QATAR
    OSUNDWA, VM
    DAWOD, ST
    EHLAYEL, M
    EUROPEAN JOURNAL OF PEDIATRICS, 1993, 152 (12) : 1001 - 1003
  • [28] ANALYSIS OF 11 CONSECUTIVE RESPIRATORY SYNCYTIAL VIRUS (RSV) OUTBREAKS IN CHILDREN
    BRANDT, CD
    KIM, HW
    ARROBIO, JO
    CHANOCK, RM
    PARROTT, RH
    PEDIATRIC RESEARCH, 1973, 7 (04) : 373 - 373
  • [29] Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children
    Garegnani, Luis
    Styrmisdottir, Lea
    Roson Rodriguez, Pablo
    Escobar Liquitay, Camila Micaela
    Esteban, Ignacio
    Franco, Juan V. A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (11):
  • [30] Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series
    Scheltema, Nienke M.
    Gentile, Angela
    Lucion, Florencia
    Nokes, D. James
    Munywoki, Patrick K.
    Madhi, Shabir A.
    Groome, Michelle J.
    Cohen, Cheryl
    Moyes, Jocelyn
    Thorburn, Kentigern
    Thamthitiwat, Somsak
    Oshitani, Hitoshi
    Lupisan, Socorro P.
    Gordon, Aubree
    Sanchez, Jose F.
    O'Brien, Katherine L.
    Gessner, Bradford D.
    Sutanto, Agustinus
    Mejias, Asuncion
    Ramilo, Octavio
    Khuri-Bulos, Najwa
    Halasa, Natasha
    de-Paris, Fernanda
    Pires, Marcia Rosane
    Spaeder, Michael C.
    Paes, Bosco A.
    Simoes, Eric A. F.
    Leung, Ting F.
    Oliveira, Maria Tereza da Costa
    Emediato, Carla Cecilia de Freitas Lazaro
    Bassat, Quique
    Butt, Warwick
    Chi, Hsin
    Aamir, Uzma Bashir
    Ali, Asad
    Lucero, Marilla G.
    Fasce, Rodrigo A.
    Lopez, Olga
    Rath, Barbara A.
    Polack, Fernando P.
    Papenburg, Jesse
    Roglic, Srdan
    Ito, Hisato
    Goka, Edward A.
    Grobbee, Diederick E.
    Nair, Harish
    Bont, Louis J.
    LANCET GLOBAL HEALTH, 2017, 5 (10): : E984 - E991